Suppr超能文献

药物代谢动力学与系统药理学整合的现状展望。

Perspective on the State of Pharmacometrics and Systems Pharmacology Integration.

机构信息

Novartis Institutes for BioMedical Research, Inc, Cambridge, Massachusetts, USA.

Metrum Research Group LLC, Tariffville, Connecticut, USA.

出版信息

CPT Pharmacometrics Syst Pharmacol. 2018 Oct;7(10):617-620. doi: 10.1002/psp4.12313. Epub 2018 Aug 21.

Abstract

Reliance on modeling and simulation in drug discovery and development has dramatically increased over the past decade. Two disciplines at the forefront of this activity, pharmacometrics and systems pharmacology (SP), emerged independently from different fields; consequently, a perception exists that only few examples integrate these approaches. Herein, we review the state of pharmacometrics and SP integration and describe benefits of combining these approaches in a model-informed drug discovery and development framework.

摘要

在过去的十年中,药物发现和开发对建模和模拟的依赖显著增加。两个处于这一活动前沿的学科,药物代谢动力学和系统药理学(SP),分别从不同的领域独立出现;因此,人们认为只有少数例子整合了这些方法。本文综述了药物代谢动力学和 SP 整合的现状,并描述了在模型指导的药物发现和开发框架中结合这些方法的好处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b5/6202472/cdefe863f6ca/PSP4-7-617-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验